| Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients N Kamar, F Abravanel, O Marion, C Couat, J Izopet, A Del Bello New England Journal of Medicine 385 (7), 661-662, 2021 | 863 | 2021 |
| 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection AJ Demetris, C Bellamy, SG Hübscher, J O’leary, PS Randhawa, S Feng, ... American Journal of Transplantation 16 (10), 2816-2835, 2016 | 528 | 2016 |
| Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation N Kamar, O Marion, L Rostaing, O Cointault, D Ribes, L Lavayssière, ... American Journal of Transplantation 16 (5), 1474-1479, 2016 | 243 | 2016 |
| Safety and immunogenicity of anti–SARS-CoV-2 messenger RNA vaccines in recipients of solid organ transplants O Marion, A Del Bello, F Abravanel, C Couat, S Faguer, L Esposito, ... Annals of internal medicine 174 (9), 1336-1338, 2021 | 151 | 2021 |
| Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients C Couchoud, F Bayer, C Ayav, C Béchade, P Brunet, F Chantrel, L Frimat, ... Kidney international 98 (6), 1519-1529, 2020 | 148 | 2020 |
| Efficiency of a boost with a third dose of anti-SARS-CoV-2 messenger RNA-based vaccines in solid organ transplant recipients A Del Bello, F Abravanel, O Marion, C Couat, L Esposito, L Lavayssière, ... American Journal of Transplantation 22 (1), 322-323, 2022 | 145 | 2022 |
| Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis X Iriart, TC Belval, J Fillaux, L Esposito, RA Lavergne, ... American journal of transplantation 15 (1), 190-199, 2015 | 140 | 2015 |
| Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept N Chavarot, A Ouedrani, O Marion, M Leruez-Ville, E Vilain, M Baaziz, ... Transplantation 105 (9), e94-e95, 2021 | 129 | 2021 |
| Assessment of 4 doses of SARS-CoV-2 messenger RNA–based vaccine in recipients of a solid organ transplant N Kamar, F Abravanel, O Marion, R Romieu-Mourez, C Couat, A Del Bello, ... JAMA network open 4 (11), e2136030-e2136030, 2021 | 117 | 2021 |
| Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy A Del Bello, N Congy-Jolivet, F Sallusto, C Guilbeau-Frugier, ... Clinical Journal of the American Society of Nephrology 7 (8), 1310-1319, 2012 | 115 | 2012 |
| High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients N Longlune, MB Nogier, M Miedougé, C Gabilan, C Cartou, B Seigneuric, ... Nephrology Dialysis Transplantation 36 (9), 1704-1709, 2021 | 112 | 2021 |
| Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients A Del Bello, N Congy-Jolivet, F Muscari, L Lavayssière, L Esposito, ... American Journal of Transplantation 14 (4), 867-875, 2014 | 110 | 2014 |
| Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes G Canaud, N Kamar, D Anglicheau, L Esposito, M Rabant, LH Noël, ... American journal of transplantation 13 (8), 2179-2185, 2013 | 109 | 2013 |
| Deleterious impact of donor-specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation T Bachelet, C Martinez, A Del Bello, L Couzi, S Kejji, G Guidicelli, ... Transplantation 100 (1), 159-166, 2016 | 83 | 2016 |
| De novo donor‐specific anti‐HLA antibodies mediated rejection in liver‐transplant patients A Del Bello, N Congy‐Jolivet, M Danjoux, F Muscari, L Lavayssière, ... Transplant international 28 (12), 1371-1382, 2015 | 82 | 2015 |
| An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients N Kamar, S Lhomme, F Abravanel, O Cointault, L Esposito, ... Transplantation 99 (10), 2124-2131, 2015 | 81 | 2015 |
| High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation A Del Bello, N Congy-Jolivet, M Danjoux, F Muscari, L Lavayssière, ... World journal of gastroenterology 24 (16), 1795, 2018 | 78 | 2018 |
| Impact of early blood transfusion after kidney transplantation on the incidence of donor‐specific anti‐HLA antibodies I Ferrandiz, N Congy‐Jolivet, A Del Bello, B Debiol, K Trébern‐Launay, ... American Journal of Transplantation 16 (9), 2661-2669, 2016 | 78 | 2016 |
| Successful treatment of hepatitis E virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin A Del Bello, C Guilbeau‐Frugier, AG Josse, L Rostaing, J Izopet, N Kamar Transplant Infectious Disease 17 (2), 279-283, 2015 | 70 | 2015 |
| Hepatitis E virus-induced severe myositis A Del Bello, MC Arné-Bes, L Lavayssière, N Kamar Journal of hepatology 57 (5), 1152-1153, 2012 | 70 | 2012 |
